Concepedia

Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group

Fernando Calais da Silva, Fernando Calais da Silva, Frederico Gonçalves, Américo Santos, Jan Kliment, Peter Whelan, N. Antoniou, Spiro Pastidis, Anton Marques Queimadelos, Chris Robertson

European Urology · 2013 · 75 citations · 16 references

Open access

References

16

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Yoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 108.7K citations

Natural Sciences, Biostatistics, A/b Testing +13

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Jason P. Fine · Journal of the American Statistical Association · 1999 · 13.6K citations

Public Health, Biostatistics, Cost-effectiveness Analysis +15

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

The Annals of Statistics · 1988 · 5K citations · Full text

Public Health, Biostatistics, Risk Analysis +15

Guidelines on Prostate Cancer

Axel Heidenreich, Joaquim Bellmunt, M. Bolla et al. · 2013 · 864 citations

Medicine, Oncology, Urology +12

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.

Nicholas Bruchovsky, Paul S. Rennie, Andrew J. Coldman et al. · PubMed · 1990 · 314 citations

Medicine, Endocrinology, Oncology +17